Screening

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Chronisch hartfalenPublished by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2024Insuffisance cardiaque chroniquePublished by: Groupe de Travail Développement de recommmandations de première ligneLast published: 2024Chronische nierinsufficiëntiePublished by: Domus Medica | SSMGLast published: 2012Insuffisance rénale chroniquePublished by: Domus Medica | SSMGLast published: 2012

There is no evidence to support screening for HFpEF in the general asymptomatic population; however, meticulous attention to cardiovascular risk factor modification is crucial at every physician review. Echocardiography should be performed only in the appropriate clinical scenario when signs and symptoms of heart failure are present or when underlying structural heart disease is suspected or needs to be excluded (e.g., hypertension). Clinical evaluation is paramount in screening these patients.

Risk factors: comorbidities and causes

Screening for risk factors such as hypertension, diabetes, and obesity should be performed in accordance with individual guidelines for these conditions. Since risk factor modification is crucial to the management of HFpEF, screening for these risk factors is encouraged.

Use of this content is subject to our disclaimer